Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.

Aberer F, Pferschy PN, Tripolt NJ, Sourij C, Obermayer AM, Prüller F, Novak E, Reitbauer P, Kojzar H, Prietl B, Kofler S, Brunner M, Svehlikova E, Stojakovic T, Scharnagl H, Oulhaj A, Aziz F, Riedl R, Sourij H.

Diabetes Obes Metab. 2019 Oct 8. doi: 10.1111/dom.13889. [Epub ahead of print]

PMID:
31595635
2.

Association of soluble CD40L with short-term and long-term cardiovascular and all-cause mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

Gergei I, Kälsch T, Scharnagl H, Kleber ME, Zirlik A, März W, Krämer BK, Kälsch AI.

Atherosclerosis. 2019 Sep 14. pii: S0021-9150(19)31478-9. doi: 10.1016/j.atherosclerosis.2019.09.004. [Epub ahead of print]

PMID:
31558283
3.

Monoacylglycerol lipase inhibition protects from liver injury in mouse models of sclerosing cholangitis.

Tardelli M, Bruschi FV, Fuchs CD, Claudel T, Auer N, Kunczer V, Baumgartner M, Ronda OAHO, Jan Verkade H, Stojakovic T, Scharnagl H, Habib A, Zimmermann R, Lotersztajn S, Trauner M.

Hepatology. 2019 Sep 10. doi: 10.1002/hep.30929. [Epub ahead of print]

PMID:
31505038
4.

Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays.

Scharnagl H, Stojakovic T, Dieplinger B, Dieplinger H, Erhart G, Kostner GM, Herrmann M, März W, Grammer TB.

Atherosclerosis. 2019 Oct;289:206-213. doi: 10.1016/j.atherosclerosis.2019.08.015. Epub 2019 Aug 27.

5.

Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health study.

Pusceddu I, Herrmann W, Kleber ME, Scharnagl H, März W, Herrmann M.

Aging (Albany NY). 2019 Sep 6;11(17):7083-7097. doi: 10.18632/aging.102238. Epub 2019 Sep 6.

6.

Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS.

Torner M, Mangal A, Scharnagl H, Jansen C, Praktiknjo M, Queck A, Gu W, Schierwagen R, Lehmann J, Uschner FE, Graf C, Strassburg CP, Fernandez J, Stojakovic T, Woitas R, Trebicka J.

Liver Int. 2019 Aug 25. doi: 10.1111/liv.14230. [Epub ahead of print]

PMID:
31448496
7.

Long- and short-term association of low-grade systemic inflammation with cardiovascular mortality in the LURIC study.

Kälsch AI, Scharnagl H, Kleber ME, Windpassinger C, Sattler W, Leipe J, Krämer BK, März W, Malle E.

Clin Res Cardiol. 2019 Jul 1. doi: 10.1007/s00392-019-01516-9. [Epub ahead of print]

PMID:
31263995
8.

Serum concentrations of free fatty acids are associated with 3-month mortality in acute heart failure patients.

Degoricija V, Trbušić M, Potočnjak I, Radulović B, Pregartner G, Berghold A, Scharnagl H, Stojakovic T, Tiran B, Frank S.

Clin Chem Lab Med. 2019 Oct 25;57(11):1799-1804. doi: 10.1515/cclm-2019-0037.

PMID:
31188747
9.

Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function.

Trakaki A, Sturm GJ, Pregartner G, Scharnagl H, Eichmann TO, Trieb M, Knuplez E, Holzer M, Stadler JT, Heinemann A, Sturm EM, Marsche G.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1280-1292. doi: 10.1016/j.bbalip.2019.06.007. Epub 2019 Jun 8.

10.

Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the European Multicenter, Randomized Controlled DALI Lifestyle Intervention Trial.

Harreiter J, Simmons D, Desoye G, Corcoy R, Adelantado JM, Devlieger R, Galjaard S, Damm P, Mathiesen ER, Jensen DM, Andersen LLT, Dunne F, Lapolla A, Dalfra MG, Bertolotto A, Wender-Ozegowska E, Zawiejska A, Mantaj U, Hill D, Jelsma JGM, Snoek FJ, Leutner M, Lackinger C, Worda C, Bancher-Todesca D, Scharnagl H, van Poppel MNM, Kautzky-Willer A.

Diabetes Care. 2019 Aug;42(8):1380-1389. doi: 10.2337/dc19-0418. Epub 2019 Jun 10.

PMID:
31182492
11.

Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.

Pusceddu I, Herrmann W, Kleber ME, Scharnagl H, Hoffmann MM, Winklhofer-Roob BM, März W, Herrmann M.

Eur J Nutr. 2019 May 25. doi: 10.1007/s00394-019-01993-8. [Epub ahead of print]

PMID:
31129702
12.

Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number.

Trieb M, Kornej J, Knuplez E, Hindricks G, Thiele H, Sommer P, Scharnagl H, Dagres N, Dinov B, Bollmann A, Husser D, Marsche G, Buettner P.

Basic Res Cardiol. 2019 May 8;114(4):27. doi: 10.1007/s00395-019-0735-0.

PMID:
31069509
13.

Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption.

Tardelli M, Bruschi FV, Claudel T, Fuchs CD, Auer N, Kunczer V, Stojakovic T, Scharnagl H, Habib A, Grabner GF, Zimmermann R, Lotersztajn S, Trauner M.

J Lipid Res. 2019 Jul;60(7):1284-1292. doi: 10.1194/jlr.M093369. Epub 2019 May 2.

PMID:
31048404
14.

Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study).

Grammer TB, Scharnagl H, Dressel A, Kleber ME, Silbernagel G, Pilz S, Tomaschitz A, Koenig W, Mueller-Myhsok B, März W, Strnad P.

Clin Chem. 2019 Jul;65(7):849-861. doi: 10.1373/clinchem.2018.297242. Epub 2019 Mar 27.

PMID:
30917972
15.

Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study.

Hollstein T, Vogt A, Grenkowitz T, Stojakovic T, März W, Laufs U, Bölükbasi B, Steinhagen-Thiessen E, Scharnagl H, Kassner U.

Vascul Pharmacol. 2019 May;116:8-15. doi: 10.1016/j.vph.2019.03.002. Epub 2019 Mar 23.

PMID:
30910670
16.

Cardiovascular risk algorithms in primary care: Results from the DETECT study.

Grammer TB, Dressel A, Gergei I, Kleber ME, Laufs U, Scharnagl H, Nixdorff U, Klotsche J, Pieper L, Pittrow D, Silber S, Wittchen HU, März W.

Sci Rep. 2019 Jan 31;9(1):1101. doi: 10.1038/s41598-018-37092-7.

17.

LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study.

Silbernagel G, Scharnagl H, Kleber ME, Delgado G, Stojakovic T, Laaksonen R, Erdmann J, Rankinen T, Bouchard C, Landmesser U, Schunkert H, März W, Grammer TB.

Atherosclerosis. 2019 Mar;282:37-44. doi: 10.1016/j.atherosclerosis.2018.12.024. Epub 2018 Dec 28.

PMID:
30685440
18.

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography.

Sommerer C, Zeier M, Morath C, Reiser J, Scharnagl H, Stojakovic T, Delgado GE, März W, Kleber ME.

Sci Rep. 2019 Jan 24;9(1):475. doi: 10.1038/s41598-018-36960-6.

19.

HDL subclasses and mortality in acute heart failure patients.

Degoricija V, Potočnjak I, Gastrager M, Pregartner G, Berghold A, Scharnagl H, Stojakovic T, Tiran B, Marsche G, Frank S.

Clin Chim Acta. 2019 Mar;490:81-87. doi: 10.1016/j.cca.2018.12.020. Epub 2018 Dec 19.

20.

Recurrent tendosynovitis as a rare manifestation of a lipid disorder.

Wadsack D, Sattler H, Kleber ME, Eirich K, Scharnagl H, Fauler G, März W, Grammer TB.

J Clin Lipidol. 2019 Jan - Feb;13(1):54-61. doi: 10.1016/j.jacl.2018.10.005. Epub 2018 Oct 24.

PMID:
30459115
21.

The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption.

Silbernagel G, Steiner LK, Hollstein T, Fauler G, Scharnagl H, Stojakovic T, Schumann F, Bölükbasi B, März W, Steinhagen-Thiessen E, Laufs U, Kassner U.

J Lipid Res. 2019 Jan;60(1):161-167. doi: 10.1194/jlr.P088583. Epub 2018 Oct 15.

PMID:
30323110
22.

Acute Exercise-Induced Circulating Haematopoietic Stem and Progenitor Cells in Cardiac Patients - A Case Series.

Kröpfl JM, Tschakert G, Stelzer I, Pekovits K, Zelzer S, Dohr G, Holasek S, Stojakovic T, Scharnagl H, Spengler CM, Hofmann P.

Heart Lung Circ. 2019 Apr;28(4):e54-e58. doi: 10.1016/j.hlc.2018.05.095. Epub 2018 May 14.

PMID:
29933914
23.

A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia.

Blom WAM, Koppenol WP, Hiemstra H, Stojakovic T, Scharnagl H, Trautwein EA.

Eur J Nutr. 2019 Jun;58(4):1615-1624. doi: 10.1007/s00394-018-1706-1. Epub 2018 May 3.

24.

Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis.

Pollheimer MJ, Racedo S, Mikels-Vigdal A, Marshall D, Bowlus C, Lackner C, Madl T, Karlsen TH, Hov JR, Lyman SK, Adamkewicz J, Smith V, Moreau E, Zollner G, Eide TJ, Stojakovic T, Scharnagl H, Gruber HJ, Stauber RE, Trauner M, Fickert P.

J Hepatol. 2018 Aug;69(2):368-377. doi: 10.1016/j.jhep.2018.04.009. Epub 2018 Apr 28.

PMID:
29709678
25.

Renal function, N-terminal Pro-B-Type natriuretic peptide, propeptide big-endothelin and patients with heart failure and preserved ejection fraction.

Gergei I, Krämer BK, Scharnagl H, Stojakovic T, März W.

Peptides. 2019 Jan;111:112-117. doi: 10.1016/j.peptides.2018.04.003. Epub 2018 Apr 21.

PMID:
29684593
26.

Vitamin D supplementation and lipoprotein metabolism: A randomized controlled trial.

Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, Aberer F, Lerchbaum E, Obermayer-Pietsch B, Pieber TR, März W, Tomaschitz A, Pilz S.

J Clin Lipidol. 2018 May - Jun;12(3):588-596.e4. doi: 10.1016/j.jacl.2018.03.079. Epub 2018 Mar 15.

PMID:
29653812
27.

Elevated Cardiac Troponin T in Patients With Skeletal Myopathies.

Schmid J, Liesinger L, Birner-Gruenberger R, Stojakovic T, Scharnagl H, Dieplinger B, Asslaber M, Radl R, Beer M, Polacin M, Mair J, Szolar D, Berghold A, Quasthoff S, Binder JS, Rainer PP.

J Am Coll Cardiol. 2018 Apr 10;71(14):1540-1549. doi: 10.1016/j.jacc.2018.01.070.

28.

Prospective cohort studies of beta-trace protein and mortality in haemodialysis patients and patients undergoing coronary angiography.

Enko D, Meinitzer A, Scharnagl H, Stojakovic T, Kleber ME, Delgado GE, Zelzer S, Drechsler C, Krämer BK, Wanner C, März W, Woitas RP.

Nephrol Dial Transplant. 2018 Nov 1;33(11):1984-1991. doi: 10.1093/ndt/gfy025.

PMID:
29474602
29.

Prognostic Value of High-Sensitivity Versus Conventional Cardiac Troponin T Assays Among Patients With Type 2 Diabetes Mellitus Undergoing Maintenance Hemodialysis.

Keller T, Wanner C, Krane V, Kraus D, Genser B, Scharnagl H, März W, Drechsler C.

Am J Kidney Dis. 2018 Jun;71(6):822-830. doi: 10.1053/j.ajkd.2017.10.016. Epub 2018 Jan 6.

PMID:
29310884
30.

Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection Fraction.

Schuett K, Kleber ME, Scharnagl H, Lorkowski S, März W, Niessner A, Marx N, Meinitzer A.

J Am Coll Cardiol. 2017 Dec 26;70(25):3202-3204. doi: 10.1016/j.jacc.2017.10.064. No abstract available.

31.

Combined serum free light chain levels are associated with carotid atherosclerosis in type 2 diabetes mellitus.

Aberer F, Tripolt NJ, Scharnagl H, Zedler J, Eder M, Oulhaj A, Stojakovic T, Sourij H.

Diab Vasc Dis Res. 2018 Mar;15(2):162-164. doi: 10.1177/1479164117743939. Epub 2017 Nov 30.

PMID:
29189047
32.

High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality.

Silbernagel G, Pagel P, Pfahlert V, Genser B, Scharnagl H, Kleber ME, Delgado G, Ohrui H, Ritsch A, Grammer TB, Koenig W, März W.

Clin Chem. 2017 Dec;63(12):1886-1896. doi: 10.1373/clinchem.2017.275636. Epub 2017 Oct 11.

33.

Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein.

Schilcher I, Kern S, Hrzenjak A, Eichmann TO, Stojakovic T, Scharnagl H, Duta-Mare M, Kratky D, Marsche G, Frank S.

Sci Rep. 2017 Oct 2;7(1):12485. doi: 10.1038/s41598-017-12882-7.

34.

Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.

Schmidt N, Schmidt B, Dressel A, Gergei I, Klotsche J, Pieper L, Scharnagl H, Kleber ME, März W, Lehnert H, Pittrow D, Stalla G, Wittchen HU, Grammer TB.

Atherosclerosis. 2017 Nov;266:24-30. doi: 10.1016/j.atherosclerosis.2017.08.019. Epub 2017 Aug 19.

PMID:
28946037
35.

FXR controls CHOP expression in steatohepatitis.

Fuchs CD, Claudel T, Scharnagl H, Stojakovic T, Trauner M.

FEBS Lett. 2017 Oct;591(20):3360-3368. doi: 10.1002/1873-3468.12845. Epub 2017 Oct 11.

36.

Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis.

Voortman MM, Pekar T, Bachmayer D, Archelos JJ, Stojakovic T, Scharnagl H, Ropele S, Pichler A, Enzinger C, Fuchs S, Fazekas F, Seifert-Held T, Khalil M.

Mult Scler J Exp Transl Clin. 2017 Aug 23;3(3):2055217317727294. doi: 10.1177/2055217317727294. eCollection 2017 Jul-Sep.

37.

ST2 predicts survival in patients undergoing transcatheter aortic valve implantation.

Schmid J, Stojakovic T, Zweiker D, Scharnagl H, Maderthaner RD, Scherr D, Maier R, Schmidt A, März W, Binder JS, Rainer PP.

Int J Cardiol. 2017 Oct 1;244:87-92. doi: 10.1016/j.ijcard.2017.06.066. Epub 2017 Jun 19.

PMID:
28651919
38.

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.

Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, Blankenberg S, Waldeyer C, Sinning C, Schnabel RB, Lackner KJ, Vlachopoulou E, Nygård O, Svingen GFT, Pedersen ER, Tell GS, Sinisalo J, Nieminen MS, Laaksonen R, Trompet S, Smit RAJ, Sattar N, Jukema JW, Groesdonk HV, Delgado G, Stojakovic T, Pilbrow AP, Cameron VA, Richards AM, Doughty RN, Gong Y, Cooper-DeHoff R, Johnson J, Scholz M, Beutner F, Thiery J, Smith JG, Vilmundarson RO, McPherson R, Stewart AFR, Cresci S, Lenzini PA, Spertus JA, Olivieri O, Girelli D, Martinelli NI, Leiherer A, Saely CH, Drexel H, Mündlein A, Braund PS, Nelson CP, Samani NJ, Kofink D, Hoefer IE, Pasterkamp G, Quyyumi AA, Ko YA, Hartiala JA, Allayee H, Tang WHW, Hazen SL, Eriksson N, Held C, Hagström E, Wallentin L, Åkerblom A, Siegbahn A, Karp I, Labos C, Pilote L, Engert JC, Brophy JM, Thanassoulis G, Bogaty P, Szczeklik W, Kaczor M, Sanak M, Virani SS, Ballantyne CM, Lee VV, Boerwinkle E, Holmes MV, Horne BD, Hingorani A, Asselbergs FW, Patel RS; GENIUS-CHD consortium, Krämer BK, Scharnagl H, Fliser D, März W, Speer T.

Lancet Diabetes Endocrinol. 2017 Jul;5(7):534-543. doi: 10.1016/S2213-8587(17)30096-7. Epub 2017 May 26.

39.

Circulating proprotein convertase subtilisin-kexin type 9, all-cause mortality, and cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health study.

Silbernagel G, Scharnagl H, Kleber ME, Stojakovic T, März W.

Eur J Prev Cardiol. 2017 Jul;24(10):1095-1101. doi: 10.1177/2047487317693938. Epub 2017 Jan 1.

PMID:
28436724
40.

CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.

Wakula P, Neumann B, Kienemund J, Thon-Gutschi E, Stojakovic T, Manninger M, Scherr D, Scharnagl H, Kapl M, Pieske B, Heinzel FR.

Europace. 2017 Apr 1;19(4):544-551. doi: 10.1093/europace/euw101.

PMID:
28431065
41.

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.

Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, Schwedhelm E, Böger RH, Laufs U, von Eckardstein A, Landmesser U, Lüscher TF, Fliser D, März W, Meinitzer A, Speer T.

Eur Heart J. 2017 May 21;38(20):1597-1607. doi: 10.1093/eurheartj/ehx118.

PMID:
28379378
42.

HDL cholesterol: reappraisal of its clinical relevance.

März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U.

Clin Res Cardiol. 2017 Sep;106(9):663-675. doi: 10.1007/s00392-017-1106-1. Epub 2017 Mar 24. Review.

43.

Serum Uromodulin and Mortality Risk in Patients Undergoing Coronary Angiography.

Delgado GE, Kleber ME, Scharnagl H, Krämer BK, März W, Scherberich JE.

J Am Soc Nephrol. 2017 Jul;28(7):2201-2210. doi: 10.1681/ASN.2016111162. Epub 2017 Feb 27.

44.

Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortality.

Woitas RP, Scharnagl H, Kleber ME, Delgado GE, Grammer TB, Pichler M, Krämer BK, März W, Stojakovic T.

PLoS One. 2017 Feb 16;12(2):e0171574. doi: 10.1371/journal.pone.0171574. eCollection 2017.

45.

Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension.

Grübler MR, Gaksch M, Kienreich K, Verheyen ND, Schmid J, Müllner C, Richtig G, Scharnagl H, Trummer C, Schwetz V, Meinitzer A, Pieske B, März W, Tomaschitz A, Pilz S.

J Steroid Biochem Mol Biol. 2018 Jan;175:157-163. doi: 10.1016/j.jsbmb.2016.12.014. Epub 2016 Dec 24.

PMID:
28027911
46.

Prognostic significance of tPA/PAI-1 complex in patients with heart failure and preserved ejection fraction.

Winter MP, Kleber ME, Koller L, Sulzgruber P, Scharnagl H, Delgado G, Goliasch G, März W, Niessner A.

Thromb Haemost. 2017 Feb 28;117(3):471-478. doi: 10.1160/TH16-08-0600. Epub 2016 Dec 15.

PMID:
27975104
47.

Prognostic value of free light chains lambda and kappa in early multiple sclerosis.

Voortman MM, Stojakovic T, Pirpamer L, Jehna M, Langkammer C, Scharnagl H, Reindl M, Ropele S, Seifert-Held T, Archelos JJ, Fuchs S, Enzinger C, Fazekas F, Khalil M.

Mult Scler. 2017 Oct;23(11):1496-1505. doi: 10.1177/1352458516681503. Epub 2016 Nov 29.

PMID:
27899552
48.

Serum bile acids in term and preterm neonates: A case-control study determining reference values and the influence of early-onset sepsis.

Zöhrer E, Resch B, Scharnagl H, Schlagenhauf A, Fauler G, Stojakovic T, Hofer N, Lang U, Jahnel J.

Medicine (Baltimore). 2016 Nov;95(44):e5219.

49.

[Clinical importance of HDL cholesterol].

März W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U.

Herz. 2017 Feb;42(1):58-66. doi: 10.1007/s00059-016-4499-0. Epub 2016 Nov 14. Review. German.

PMID:
27844137
50.

Propeptide big-endothelin, N-terminal-pro brain natriuretic peptide and mortality. The Ludwigshafen risk and cardiovascular health (LURIC) study.

Gergei I, Krämer BK, Scharnagl H, Stojakovic T, März W, Mondorf U.

Biomarkers. 2017 May - Jun;22(3-4):315-320. doi: 10.1080/1354750X.2016.1252969. Epub 2016 Nov 9.

PMID:
27788598

Supplemental Content

Loading ...
Support Center